Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2013-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/jpet.112.202788PMID 23475901
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Crystal Structure of the Calcium Release–Activated Calcium Channel Orai

  2012cited by this paper
• Immunodeficiency due tomutations in ORAI 1 and STIM 1

  2010cited by this paper
• Immunodeficiency due to mutations in ORAI1 and STIM1.

  2010cited by this paper
• ORAI1 deficiency and lack of store-operated Ca2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia.

  2009cited by this paper
• Extracellular Ion Channel Inhibitor Antibodies

  2009cited by this paper
• CRAC channelopathies

  2009cited by this paper
• Mitochondrial regulation of store-operated CRAC channels.

  2008cited by this paper
• High-affinity binding measurements of antibodies to cell-surface-expressed antigens.

  2008cited by this paper
• Novel potent and selective Ca2+ release-activated Ca2+ (CRAC) channel inhibitors. Part 3: synthesis and CRAC channel inhibitory activity of 4'-[(trifluoromethyl)pyrazol-1-yl]carboxanilides.

  2008cited by this paper
• Calcium signalling in lymphocyte activation and disease

  2007cited by this paper
• Activation of muscarinic receptors reduces store-operated Ca2+ entry in HEK293 cells.

  2007cited by this paper
• YM-58483, a selective CRAC channel inhibitor, prevents antigen-induced airway eosinophilia and late phase asthmatic responses via Th2 cytokine inhibition in animal models.

  2007cited by this paper
• Biochemical and Functional Characterization of Orai Proteins*

  2007cited by this paper
• Novel potent and selective calcium-release-activated calcium (CRAC) channel inhibitors. Part 2: Synthesis and inhibitory activity of aryl-3-trifluoromethylpyrazoles.

  2006cited by this paper
• CRACM1 Is a Plasma Membrane Protein Essential for Store-Operated Ca2+ Entry

  2006cited by this paper
• Orai1 is an essential pore subunit of the CRAC channel

  2006cited by this paper
• Novel potent and selective calcium-release-activated calcium (CRAC) channel inhibitors. Part 1: synthesis and inhibitory activity of 5-(1-methyl-3-trifluoromethyl-1H-pyrazol-5-yl)-2-thiophenecarboxamides.

  2006cited by this paper
• Genome-wide RNAi screen of Ca(2+) influx identifies genes that regulate Ca(2+) release-activated Ca(2+) channel activity.

  2006cited by this paper
• A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function

  2006cited by this paper
• Cell proliferation depends on mitochondrial Ca2+ uptake: inhibition by salicylate

  2006cited by this paper
• A severe defect in CRAC Ca2+ channel activation and altered K+ channel gating in T cells from immunodeficient patients

  2005cited by this paper
• STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx.

  2005cited by this paper
• STIM1, an essential and conserved component of store-operated Ca2+ channel function

  2005cited by this paper
• Store-operated calcium channels.

  2005cited by this paper
• Lymphocyte calcium signaling from membrane to nucleus

  2005cited by this paper
• Potent Inhibition of Ca2+ Release-activated Ca2+ Channels and T-lymphocyte Activation by the Pyrazole Derivative BTP2*

  2004cited by this paper
• Calcium signalling in lymphocytes.

  2003cited by this paper
• A Pyrazole Derivative, YM-58483, Potently Inhibits Store-Operated Sustained Ca2+ Influx and IL-2 Production in T Lymphocytes

  2003cited by this paper
• Ca2+/calcineurin signalling in cells of the immune system.

  2003cited by this paper
• Transcriptional regulation by calcium, calcineurin, and NFAT.

  2003cited by this paper
• Gene regulation mediated by calcium signals in T lymphocytes

  2001cited by this paper
• Calcium signaling mechanisms in T lymphocytes.

  2001cited by this paper
• Mitochondrial control of calcium-channel gating: a mechanism for sustained signaling and transcriptional activation in T lymphocytes.

  2000cited by this paper
• Regulation of the Ca2+-inhibitable Adenylyl Cyclase Type VI by Capacitative Ca2+ Entry Requires Localization in Cholesterol-rich Domains*

  2000cited by this paper
• Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity.

  2000cited by this paper
• Store depletion triggers the calcium release-activated calcium current (ICRAC) in macrovascular endothelial cells: a comparison with Jurkat and embryonic kidney cell lines

  1998cited by this paper
• Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice

  1997cited by this paper
• The calcium current activated by T cell receptor and store depletion in human lymphocytes is absent in a primary immunodeficiency.

  1994cited by this paper
• Calcium release‐activated calcium current in rat mast cells.

  1993cited by this paper
• The signal for capacitative calcium entry.

  1993cited by this paper
• A model for receptor-regulated calcium entry.

  1986cited by this paper

• Targeting store-operated Ca2+ entry as a novel strategy to overcome treatment resistance in melanoma.

  2026cites this paper
• Calcium response via CRAC channels in human synovial cells induced by shear stress in rheumatoid arthritis

  2025cites this paper
• Store-operated calcium entry-based targets for novel cancer therapeutic development.

  2025cites this paper
• Advancements in the conservation of the conformational epitope of membrane protein immunogens

  2025cites this paper
• ORAI1 mutation with mixed loss- and gain-of-function properties causes immunodeficiency and HLH

  2025cites this paper
• Targeting ion channels: innovative approaches to combat cancer drug resistance

  2025cites this paper
• ORAI Ca2+ Channels in Cancers and Therapeutic Interventions

  2024cites this paper
• ORAI1 inhibition as an efficient preclinical therapy for tubular aggregate myopathy and Stormorken syndrome

  2024cites this paper
• SOCE as a regulator of neuronal activity

  2023cites this paper
• Orai1 Ca2+ channel modulators as therapeutic tools for treating cancer: Emerging evidence!

  2023cites this paper
• Molecular action mechanisms of two novel and selective calcium release-activated calcium channel antagonists.

  2023cites this paper
• New frontiers in the design and discovery of therapeutics that target calcium ion signaling: a novel approach in the fight against cancer

  2023cites this paper
• Pharmacological blockade of KV1.3 channel as a promising treatment in autoimmune diseases

  2022cites this paper
• Development of Store-Operated Calcium Entry-Targeted Compounds in Cancer

  2021cites this paper
• Isoform-Specific Properties of Orai Homologues in Activation, Downstream Signaling, Physiology and Pathophysiology

  2021cites this paper
• Therapeutic Antibodies Targeting Potassium Ion Channels.

  2021cites this paper
• Overcoming challenges of HERG potassium channel liability through rational design: Eag1 inhibitors for cancer treatment

  2021cites this paper
• Antibody Therapies Targeting Complex Membrane Proteins

  2021cites this paper
• Gating and regulation of the calcium release‐activated calcium channel: Recent progress from experiments and molecular modeling

  2020cites this paper
• Calcium Permeable Channels in Cancer Hallmarks

  2020cites this paper
• Orai3: Oncochannel with therapeutic potential.

  2020cites this paper
• HERG channel and cancer: A mechanistic review of carcinogenic processes and therapeutic potential.

  2020cites this paper
• Binding Affinity Determination of Therapeutic Antibodies to Membrane Protein Targets: Kinetic Exclusion Assay Using Cellular Membranes for anti-CD20 Antibody.

  2020cites this paper
• Store-Operated Ca2+ Channels: Mechanism, Function, Pharmacology, and Therapeutic Targets.

  2020cites this paper
• Endoplasmic reticulum–mitochondria interplay in chronic pain: The calcium connection

  2020cites this paper
• Potassium and Calcium Channel Complexes as Novel Targets for Cancer Research.

  2020cites this paper
• Contributions of natural products to ion channel pharmacology.

  2020cites this paper
• Structural and Mechanistic Insights of CRAC Channel as a Drug Target in Autoimmune Disorder.

  2019cites this paper
• Monoclonal Antibodies Targeting Ion Channels and Their Therapeutic Potential

  2019cites this paper
• Genetic Manipulation of Calcium Release-Activated Calcium Channel 1 Modulates the Multipotency of Human Cartilage-Derived Mesenchymal Stem Cells

  2019cites this paper
• Antibodies and venom peptides: New therapeutic modalities for ion channels

  2019cites this paper
• Ion Channel Targeting with Antibodies and Antibody Fragments for Cancer Diagnosis

  2019cites this paper
• Phosphoproteomics reveals conserved exercise‐stimulated signaling and AMPK regulation of store‐operated calcium entry

  2019cites this paper
• Ion Channels and Transporters as Cancer Biomarkers and Targets for Diagnostics with Antibodies

  2019cites this paper
• Antibodies and venom peptides: new modalities for ion channels

  2019cites this paper
• Therapeutic Monoclonal Antibodies to Complex Membrane Protein Targets: Antigen Generation and Antibody Discovery Strategies

  2018cites this paper
• Physiological CRAC channel activation and pore properties require STIM1 binding to all six Orai1 subunits

  2018cites this paper
• Screening Strategies for the Discovery of Ion Channel Monoclonal Antibodies

  2018cites this paper
• Biophysical properties of the ORAI1 channel in the context of tubular aggregate myopathy

  2018cites this paper
• Modulating ion channel function with antibodies and nanobodies.

  2018cites this paper
• Strategies for Generating Diverse Antibody Repertoires Using Transgenic Animals Expressing Human Antibodies

  2018cites this paper
• Ion channelopathies of the immune system.

  2018cites this paper
• CRAC channels as targets for drug discovery and development.

  2018cites this paper
• Peptide mimetics of immunoglobulin A (IgA) and FcαRI block IgA‐induced human neutrophil activation and migration

  2017cites this paper
• ORAI2 modulates store-operated calcium entry and T cell-mediated immunity

  2017cites this paper
• ORAI1 mutations abolishing store‐operated Ca2+ entry cause anhidrotic ectodermal dysplasia with immunodeficiency

  2017cites this paper
• Efficiency and Safety of CRAC Inhibitors in Human Rheumatoid Arthritis Xenograft Models

  2017cites this paper
• Rôle de la signalisation calcique dans la leucémie myéloïde chronique

  2016cites this paper
• Discovery of functional monoclonal antibodies targeting G-protein-coupled receptors and ion channels.

  2016cites this paper
• Functional Analysis of Orai1 Concatemers Supports a Hexameric Stoichiometry for the CRAC Channel.

  2016cites this paper
• Discovery and bio‐optimization of human antibody therapeutics using the XenoMouse® transgenic mouse platform

  2016cites this paper
• Targeting Stim and Orai Proteins as an Alternative Approach in Anticancer Therapy.

  2016cites this paper
• Extracellular Calcium Has Multiple Targets to Control Cell Proliferation.

  2016cites this paper
• Targeting calcium signaling in cancer therapy

  2016cites this paper
• Cell type–specific glycosylation of Orai1 modulates store-operated Ca2+ entry

  2016cites this paper
• Calcium channels: the potential therapeutic targets for inflammatory bone destruction of rheumatoid arthritis

  2016cites this paper
• Store-operated Ca2+ channels in airway epithelial cell function and implications for asthma

  2016cites this paper
• Understanding autoimmunity: The ion channel perspective.

  2016cites this paper
• Anchoring protein AKAP79‐mediated PKA phosphorylation of STIM1 determines selective activation of the ARC channel, a store‐independent Orai channel

  2015cites this paper
• Store-Operated Calcium Channels.

  2015cites this paper
• Discovery of Functional Antibodies Targeting Ion Channels

  2015influential citation
• Ion channels in innate and adaptive immunity.

  2015cites this paper
• of Rituximab in Non-Hodgkin B LymphomasEffects Represses CD95-Dependent Apoptotic Localized Store-Operated Calcium Influx

  2015cites this paper
• A store‐operated calcium channel inhibitor attenuates collagen‐induced arthritis

  2015cites this paper
• Inhibition of CRAC with a human anti-ORAI1 monoclonal antibody inhibits T-cell-derived cytokine production but fails to inhibit a T-cell-dependent antibody response in the cynomolgus monkey

  2015influential citation
• SOCE and cancer: Recent progress and new perspectives

  2015cites this paper
• Localized Store-Operated Calcium Influx Represses CD95-Dependent Apoptotic Effects of Rituximab in Non-Hodgkin B Lymphomas

  2015cites this paper
• Systemic Lentivirus-Mediated Delivery of Short Hairpin RNA Targeting Calcium Release–Activated Calcium Channel 3 as Gene Therapy for Collagen-Induced Arthritis

  2015cites this paper
• Calcio, canales, señalización intracelular y autoinmunidad

  2014cites this paper
• This information is current as ArthritisGene Therapy for Collagen-Induced Activated Calcium Channel 3 as − Release Short Hairpin RNA Targeting Calcium Systemic Lentivirus-Mediated Delivery of Maeyama

  2014cites this paper
• Expression of ORAI1, a Plasma Membrane Resident Subunit of the CRAC Channel, in Rodent and Non-rodent Species

  2014cites this paper
• Calcium, Channels, Intracellular Signaling and Autoimmunity

  2014cites this paper
• Calcium, channels, intracellular signaling and autoimmunity.

  2014cites this paper
• Antibody-Mediated Targeting of the Orai1 Calcium Channel Inhibits T Cell Function

  2013cites this paper